CLASS II Drug recall · Reported 4 Nov 2020 · FDA Enforcement Report

Hydrocortisone butyrate Cream, 0.1% tubes recalled

Bausch Health Companies is recalling Hydrocortisone butyrate Cream, 0.1% tubes, distributed nationwide in the US. The recall was initiated on 13 Jul 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 18125C, Exp. Date 09/2020; 19079B, Exp. Date 5/2021; 19142B, Exp. Date 09/2021; 19167B, Exp. Date 10/2021
Quantity recalled35424 units

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0054-2021
FDA event ID
86557
Recalling firm
Bausch Health Companies, Bridgewater, NJ
Classification
Class II
Status
Terminated
Recall initiated
13 Jul 2020
FDA classified
26 Oct 2020
Reported
4 Nov 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

13 Jul 2020Recall initiated by company
26 Oct 2020Classified by FDA+105 days
4 Nov 2020Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

SUBPOTENT DRUG

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Hydrocortisone butyrate Cream, 0.1%, 15-gram tubes, Rx Only, Manufactured for Oceanside Pharmaceuticals a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA, By: Ferndale Laboratories, Inc. Ferndale, MI 48220, NDC 68682-270-15

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Why was it recalled?

SUBPOTENT DRUG

Which lots are affected?

Lot #: 18125C, Exp. Date 09/2020; 19079B, Exp. Date 5/2021; 19142B, Exp. Date 09/2021; 19167B, Exp. Date 10/2021

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Bausch Health Companies

All 6

Other Hydrocortisone Butyrate recalls

All 5